Gastrointestinal Cancer News

For millions of Americans, taking a statin represents an integral part of everyday life.

The FDA has granted fast track designation to CEQ508, an investigational RNAi therapeutic for familial adenomatous polyposis, the manufacturer announced.

Occult maternal malignancies may provide a biological explanation for some discordant non-invasive prenatal test results.

Clinicians frequently underestimated the recurrence risk for patients with gastrointestinal stromal tumors, according to study results.

Updated results from the HEAT study indicated an overall survival rate of over 50% among patients with primary liver cancer when treated with ThermoDox combined with radiofrequency ablation, according to a press release from Celsion Corporation.

Survivors of young adult cancers experienced elevated rates of hospitalization compared with cancer-free controls, according to study results.

Researchers have developed a three-biomarker panel that can detect early-stage pancreatic ductal adenocarcinoma through urine analysis, which could lead to a noninvasive screening test for high-risk individuals.

A population-based cohort study in Sweden demonstrated patients with gastric precancerous lesions at all stages of progression based on Correa’s cascade increased their risk for developing gastric cancer compared with the general population.

Racial disparities in adjuvant chemotherapy receipt have recently reemerged among patients with stage III colon cancer, according to study results.

Glypicin-1 circulating exosomes may serve as a biomarker for the non-invasive detection for early-stage pancreatic cancer, according to study results.